Compare $ATOS vs $ATYR | Chartloom

Compare

$ATOS vs $ATYR

Atossa Therapeutics Inc · aTyr Pharma Inc

ATOS

Atossa Therapeutics Inc

ATYR

aTyr Pharma Inc

Compare $ATOS vs $ATYR

Comparing Atossa Therapeutics Inc and aTyr Pharma Inc

ATOSAtossa Therapeutics Inc

ATYRaTyr Pharma Inc

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

ATYRaTyr Pharma Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.1%

YTD performance

-67.6%

52W performance

-75.4%

FCF yield

-227.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATOS

ATYR

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

ATYR

aTyr Pharma Inc

Market Cap

ATOS$24M

ATYR$24M

Enterprise Value

ATOS$-2M

ATYR$9M

Price

ATOS$2.44

ATYR$0.25

P/E Ratio

ATOSN/A

ATYRN/A

P/S Ratio

ATOS145.95x

ATYR127.05x

EV/Sales

ATOS-17.14x

ATYR44.92x

EV/EBITDA

ATOS0.00x

ATYR0.00x

P/B Ratio

ATOS0.87x

ATYR0.58x

P/FCF Ratio

ATOSN/A

ATYRN/A

EV/FCF

ATOS0.05x

ATYR-0.16x

PEG Ratio

ATOSN/A

ATYRN/A

Forward P/E (NTM)

ATOSN/A

ATYRN/A

Forward P/S (NTM)

ATOSN/A

ATYRN/A

Revenue (TTM)

ATOS$0

ATYR$190K

Revenue Growth (YoY)

ATOSN/A

ATYR-19.1%

Forward Rev Growth

ATOS184.1%

ATYR2461.0%

Gross Margin (TTM)

ATOS62.5%

ATYR0.0%

Operating Margin (TTM)

ATOS0.0%

ATYR0.0%

EBITDA Margin (TTM)

ATOS0.0%

ATYR-21689.5%

Net Margin (TTM)

ATOS0.0%

ATYR-20898.4%

FCF Margin (TTM)

ATOSN/A

ATYR-28852.1%

Net Income (TTM)

ATOS$-38M

ATYR$-40M

FCF (TTM)

ATOS$-36M

ATYR$-55M

EPS (TTM)

ATOS-$4.23

ATYR$0.00

ROE (TTM)

ATOS-10299.0%

ATYR-9962.0%

ROA (TTM)

ATOS-8578.0%

ATYR-7441.0%

ROIC (TTM)

ATOS-10299.0%

ATYR-9817.0%

Cash

ATOS$26M

ATYR$16M

Debt

ATOS$0

ATYR$554K

Net Cash/Debt

ATOS$26M

ATYR$16M

Current Ratio (TTM)

ATOS5.69x

ATYR5.12x

Quick Ratio (TTM)

ATOS4.81x

ATYR5.08x

Debt/Equity (TTM)

ATOS0.00x

ATYR0.01x

Debt/Assets (TTM)

ATOS0.0%

ATYR0.0%

Interest Coverage (TTM)

ATOSN/A

ATYRN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

ATYR0.00x

Beta

ATOS1.39

ATYR0.99

52W Performance

ATOS-85.3%

ATYR-75.4%

YTD Performance

ATOS-74.2%

ATYR-67.6%

% from 52W High

ATOS-87.4%

ATYR-78.0%

% from 52W Low

ATOS43.5%

ATYR0.1%

Asset Turnover (TTM)

ATOS0.01x

ATYR0.00x

FCF Yield (TTM)

ATOS-147.1%

ATYR-227.1%

Earnings Yield (TTM)

ATOS-155.0%

ATYR-164.5%

Dividend Yield (TTM)

ATOSN/A

ATYRN/A

Rule of 40

ATOS0.0

ATYR-28,871.3

EV/GP/RG

ATOSN/A

ATYRN/A

Ticker research

View ATOS research View ATYR research

Metric	ATOS Atossa Therapeutics Inc	ATYR aTyr Pharma Inc
Market & Valuation
Market Cap	$24M	$24M
Enterprise Value	$-2M	$9M
Price	$2.44	$0.25
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	127.05x
EV/Sales	-17.14x	44.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.58x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$190K
Revenue Growth (YoY)	N/A	-19.1%
Forward Rev Growth	184.1%	2461.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-21689.5%
Net Margin (TTM)	0.0%	-20898.4%
FCF Margin (TTM)	N/A	-28852.1%
Net Income (TTM)	$-38M	$-40M
FCF (TTM)	$-36M	$-55M
EPS (TTM)	-$4.23	$0.00
ROE (TTM)	-10299.0%	-9962.0%
ROA (TTM)	-8578.0%	-7441.0%
ROIC (TTM)	-10299.0%	-9817.0%
Financial Health
Cash	$26M	$16M
Debt	$0	$554K
Net Cash/Debt	$26M	$16M
Current Ratio (TTM)	5.69x	5.12x
Quick Ratio (TTM)	4.81x	5.08x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.99
52W Performance	-85.3%	-75.4%
YTD Performance	-74.2%	-67.6%
% from 52W High	-87.4%	-78.0%
% from 52W Low	43.5%	0.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-227.1%
Earnings Yield (TTM)	-155.0%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-28,871.3
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View ATYR research

Valuation

P/S Ratio

ATYR

127.05x

ATOS

145.95x

EV/FCF

ATYR

-0.16x

ATOS

0.05x

Growth & revenue

Revenue Growth TTM

ATYR

-19.1%

Forward Revenue Growth

ATYR

2461.0%

ATOS

184.1%

Profitability & performance

Gross Margin

ATOS

62.5%

ATYR

0.0%

ROE

ATYR

-9962.0%

ATOS

-10299.0%

FCF Yield %

ATOS

-147.1%

ATYR

-227.1%

52-Week Performance

ATYR

-75.4%

ATOS

-85.3%

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

ATYR

aTyr Pharma Inc

Market Cap

ATOS$24M

ATYR$24M

Enterprise Value

ATOS$-2M

ATYR$9M

Price

ATOS$2.44

ATYR$0.25

P/E Ratio

ATOSN/A

ATYRN/A

P/S Ratio

ATOS145.95x

ATYR127.05x

EV/Sales

ATOS-17.14x

ATYR44.92x

EV/EBITDA

ATOS0.00x

ATYR0.00x

P/B Ratio

ATOS0.87x

ATYR0.58x

P/FCF Ratio

ATOSN/A

ATYRN/A

EV/FCF

ATOS0.05x

ATYR-0.16x

PEG Ratio

ATOSN/A

ATYRN/A

Forward P/E (NTM)

ATOSN/A

ATYRN/A

Forward P/S (NTM)

ATOSN/A

ATYRN/A

Revenue (TTM)

ATOS$0

ATYR$190K

Revenue Growth (YoY)

ATOSN/A

ATYR-19.1%

Forward Rev Growth

ATOS184.1%

ATYR2461.0%

Gross Margin (TTM)

ATOS62.5%

ATYR0.0%

Operating Margin (TTM)

ATOS0.0%

ATYR0.0%

EBITDA Margin (TTM)

ATOS0.0%

ATYR-21689.5%

Net Margin (TTM)

ATOS0.0%

ATYR-20898.4%

FCF Margin (TTM)

ATOSN/A

ATYR-28852.1%

Net Income (TTM)

ATOS$-38M

ATYR$-40M

FCF (TTM)

ATOS$-36M

ATYR$-55M

EPS (TTM)

ATOS-$4.23

ATYR$0.00

ROE (TTM)

ATOS-10299.0%

ATYR-9962.0%

ROA (TTM)

ATOS-8578.0%

ATYR-7441.0%

ROIC (TTM)

ATOS-10299.0%

ATYR-9817.0%

Cash

ATOS$26M

ATYR$16M

Debt

ATOS$0

ATYR$554K

Net Cash/Debt

ATOS$26M

ATYR$16M

Current Ratio (TTM)

ATOS5.69x

ATYR5.12x

Quick Ratio (TTM)

ATOS4.81x

ATYR5.08x

Debt/Equity (TTM)

ATOS0.00x

ATYR0.01x

Debt/Assets (TTM)

ATOS0.0%

ATYR0.0%

Interest Coverage (TTM)

ATOSN/A

ATYRN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

ATYR0.00x

Beta

ATOS1.39

ATYR0.99

52W Performance

ATOS-85.3%

ATYR-75.4%

YTD Performance

ATOS-74.2%

ATYR-67.6%

% from 52W High

ATOS-87.4%

ATYR-78.0%

% from 52W Low

ATOS43.5%

ATYR0.1%

Asset Turnover (TTM)

ATOS0.01x

ATYR0.00x

FCF Yield (TTM)

ATOS-147.1%

ATYR-227.1%

Earnings Yield (TTM)

ATOS-155.0%

ATYR-164.5%

Dividend Yield (TTM)

ATOSN/A

ATYRN/A

Rule of 40

ATOS0.0

ATYR-28,871.3

EV/GP/RG

ATOSN/A

ATYRN/A

Ticker research

View ATOS research View ATYR research

Metric	ATOS Atossa Therapeutics Inc	ATYR aTyr Pharma Inc
Market & Valuation
Market Cap	$24M	$24M
Enterprise Value	$-2M	$9M
Price	$2.44	$0.25
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	127.05x
EV/Sales	-17.14x	44.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.58x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$190K
Revenue Growth (YoY)	N/A	-19.1%
Forward Rev Growth	184.1%	2461.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-21689.5%
Net Margin (TTM)	0.0%	-20898.4%
FCF Margin (TTM)	N/A	-28852.1%
Net Income (TTM)	$-38M	$-40M
FCF (TTM)	$-36M	$-55M
EPS (TTM)	-$4.23	$0.00
ROE (TTM)	-10299.0%	-9962.0%
ROA (TTM)	-8578.0%	-7441.0%
ROIC (TTM)	-10299.0%	-9817.0%
Financial Health
Cash	$26M	$16M
Debt	$0	$554K
Net Cash/Debt	$26M	$16M
Current Ratio (TTM)	5.69x	5.12x
Quick Ratio (TTM)	4.81x	5.08x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.99
52W Performance	-85.3%	-75.4%
YTD Performance	-74.2%	-67.6%
% from 52W High	-87.4%	-78.0%
% from 52W Low	43.5%	0.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-227.1%
Earnings Yield (TTM)	-155.0%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-28,871.3
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View ATYR research